Detalhe da pesquisa
1.
A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 25(10): e1446-e1450, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32452588